Products for Research Use Only
RegisterLogin

ABT-263

CAT: 0013-GTR19172351-01Size: 5 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19172351-01Size:5 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Navitoclax (ABT-263) is an orally bioavailable small molecule that potently inhibits Bcl-2, Bcl-xL, and Bcl-w (Ki<1 nM), inducing apoptosis. It is widely used in cancer research, demonstrating antitumor activity in both in vitro cellular assays and in vivo xenograft models for studying programmed cell death mechanisms.
CAS Number
923564-51-6
Product Name Alternative
Navitoclax
Field of Research
Cell Biology, Neuroscience, Stem Cell & Developmental Biology
Purity
>98%
Bioactivity
Bcl-2 family inhibitor, Senolytic agent
Form
Powder
Solubility
Soluble in DMSO (up to 25 mg/ml)
Smiles
C (C1=C (CCC (C) (C) C1) C2=CC=C (Cl) C=C2) N3CCN (CC3) C4=CC=C (C (NS (=O) (=O) C5=CC (S (C (F) (F) F) (=O) =O) =C (N[C@H] (CCN6CCOCC6) CSC7=CC=CC=C7) C=C5) =O) C=C4
Molecular Formula
C47H55ClF3N5O6S3
Molecular Weight
974.6
Storage Conditions
-20°C
Notes
For research use only.
Other Product Names
4-[4-[[2- (4-chlorophenyl) -5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[ (1R) - 3- (4-morpholinyl) -1-[ (phenylthio) methyl]propyl]amino]-3-[ (trifluoromethyl) sulfonyl]-phenyl]sulfonyl]-benzamide

Related Products

CatalogName
GTR19173288-01TH-263
GTR19165632-01BLU-263
GTR19192967-01RA 263
GTR19156855-01TH-263
GTR19249761-01Antibacterial agent 263
GTR19276017-01CRBN ligand-263
GTR19250613-01Anticancer agent 263
GTR19194231Jam 2-263
GTR19198332-01Abt-288
GTR19198330-01ABT-418

Alternative Products

CatalogName
2467-25ABT-263
TRC-A112500-5MGABT 263
A3007-100ABT-263 (Navitoclax)
C16050-10mgNavitoclax (ABT-263)
285063-01Navitoclax (ABT 263)
TRC-A112502-1MGABT 263-d8
A10022-10ABT-263 10mg

Popular Products